Table 5 Top diseases and bio functions - diseases and disorders
Affected eyes of AAU patients versus eyes of healthy controls | Affected versus unaffected eyes of AAU patients | Affected eyes of bacterial keratitis patients versus eyes of healthy controls | Affected versus unaffected eyes of bacterial keratitis patients | ||||
|---|---|---|---|---|---|---|---|
Name | p-value | Name | p-value | Name | p-value | Name | p-value |
Inflammatory response | 7.17E-06 – 1.24E-45 | Inflammatory response | 4.76E-06 – 1.04E-45 | Inflammatory response | 3.46E-05 – 2.65E-42 | Inflammatory response | 1.28E-05 – 1.52E-46 |
Organismal injury and abnormalities | 7.34E-06 – 1.69E-28 | Neurological disease | 2.76E-06 – 1.18E-35 | Organismal injury and abnormalities | 3.46E-05 – 2.01E-28 | Organismal injury and abnormalities | 1.63E-05 – 6.31E-28 |
Dermatological diseases and conditions | 7.17E-06 – 5.17E-28 | Organismal injury and abnormalities | 4.76E-06 – 1.18E-35 | Dermatological diseases and conditions | 2.01E-05 – 3.20E-23 | Dermatological diseases and conditions | 9.09E-06 – 1.14E-27 |
Endocrine system disorders | 2.44E-08 – 2.82E-26 | Endocrine system disorders | 1.05E-08 – 6.43E-29 | Metabolic disease | 2.90E-05 – 2.46E-21 | Metabolic disease | 2.78E-06 – 1.22E-23 |
Metabolic disease | 3.10E-06 – 7.93E-25 | Metabolic disease | 3.15E-06 – 2.43E-27 | Endocrine system disorders | 3.07E-05 – 6.38E-20 | Neurological disease | 1.37E-05 – 3.58E-21 |